Table 1 Patient characteristics (n = 30).
Variables | Total (%) |
|---|---|
Age | |
Mean | 66 |
range | 40–87 |
Sex | |
Male | 27 (90) |
Female | 3 (10) |
Recurrent site | |
Larynx | 18 (60) |
Oropharynx | 8 (27) |
hypopharynx | 4 (13) |
Treatment before recurrence | |
Chemo-radiotherapy | 16 (53) |
Radiotherapy | 14 (47) |
Radiation dosage before recurrence | |
Median | 66.0 Gy |
Range | 60–70.2 Gy |
p16 status | |
Positive | 6 (20) |
Negative | 24 (80) |
Local recurrence | |
Early | 22 (73) |
Advance | 8 (27) |
Regional recurrence | |
Yes | 2 (7) |
No | 28 (93) |
Treatment at recurrence | |
Surgery | 22 (73) |
Chemotherapy | 3 (10) |
Cetuximab + chemotherapy | 3 (10) |
Nivolumab | 2 (7) |
Follow up (months) form recurrence | |
Median | 63.1 |
Range | 15.3–146.2 |
